2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
A correction has been published: European Heart Journal, ehaa895, https://doi.org/10.1093/eurheartj/ehaa895
Publications
8 shownCardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure th...
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Empagliflozin reduced the combined risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction, regardless...
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
BACKGROUND In patients with type 2 diabetes, inhibitors of sodium-glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization for heart failure, possibly through ...
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
International audience
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries
Most North, West, and Central European countries used p-PCI for the majority of their STEMI patients. The lack of organized p-PCI networks was associated with fewer patients ove...
Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries
Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not ...
Frequent Co-Authors
Researcher Info
- h-index
- 8
- Publications
- 9
- Citations
- 40,152
- Institution
- Semmelweis University
External Links
Identifiers
- ORCID
- 0000-0001-6514-0723
Impact Metrics
h-index
8
h-index: Number of publications with at least h citations each.